220 related articles for article (PubMed ID: 35085865)
1. A systematic review of Ebola virus disease outbreaks and an analysis of the efficacy and safety of newer drugs approved for the treatment of Ebola virus disease by the US Food and Drug Administration from 2016 to 2020.
Sivanandy P; Jun PH; Man LW; Wei NS; Mun NFK; Yii CAJ; Ying CCX
J Infect Public Health; 2022 Mar; 15(3):285-292. PubMed ID: 35085865
[TBL] [Abstract][Full Text] [Related]
2. Ebola virus disease: A review for the emergency medicine clinician.
Chavez S; Koyfman A; Gottlieb M; Brady WJ; Carius BM; Liang SY; Long B
Am J Emerg Med; 2023 Aug; 70():30-40. PubMed ID: 37196593
[TBL] [Abstract][Full Text] [Related]
3. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
Tshiani Mbaya O; Mukumbayi P; Mulangu S
Front Immunol; 2021; 12():721328. PubMed ID: 34526994
[TBL] [Abstract][Full Text] [Related]
4. Forty-two years of responding to Ebola virus outbreaks in Sub-Saharan Africa: a review.
Rugarabamu S; Mboera L; Rweyemamu M; Mwanyika G; Lutwama J; Paweska J; Misinzo G
BMJ Glob Health; 2020; 5(3):e001955. PubMed ID: 32201623
[TBL] [Abstract][Full Text] [Related]
5. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
6. The effect of Ebola virus disease on maternal health service utilisation and perinatal outcomes in West Africa: a systematic review.
Kassa ZY; Scarf V; Fox D
Reprod Health; 2022 Feb; 19(1):35. PubMed ID: 35120540
[TBL] [Abstract][Full Text] [Related]
7. Combating Ebola with Repurposed Therapeutics Using the CANDO Platform.
Chopra G; Kaushik S; Elkin PL; Samudrala R
Molecules; 2016 Nov; 21(12):. PubMed ID: 27898018
[TBL] [Abstract][Full Text] [Related]
8. Ebola virus disease: A narrative review.
Letafati A; Salahi Ardekani O; Karami H; Soleimani M
Microb Pathog; 2023 Aug; 181():106213. PubMed ID: 37355146
[TBL] [Abstract][Full Text] [Related]
9. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S; Dodd LE; Davey RT; Tshiani Mbaya O; Proschan M; Mukadi D; Lusakibanza Manzo M; Nzolo D; Tshomba Oloma A; Ibanda A; Ali R; Coulibaly S; Levine AC; Grais R; Diaz J; Lane HC; Muyembe-Tamfum JJ; ; Sivahera B; Camara M; Kojan R; Walker R; Dighero-Kemp B; Cao H; Mukumbayi P; Mbala-Kingebeni P; Ahuka S; Albert S; Bonnett T; Crozier I; Duvenhage M; Proffitt C; Teitelbaum M; Moench T; Aboulhab J; Barrett K; Cahill K; Cone K; Eckes R; Hensley L; Herpin B; Higgs E; Ledgerwood J; Pierson J; Smolskis M; Sow Y; Tierney J; Sivapalasingam S; Holman W; Gettinger N; Vallée D; Nordwall J;
N Engl J Med; 2019 Dec; 381(24):2293-2303. PubMed ID: 31774950
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.
Lee JS; Adhikari NKJ; Kwon HY; Teo K; Siemieniuk R; Lamontagne F; Chan A; Mishra S; Murthy S; Kiiza P; Hajek J; Bah EI; Lamah MC; Kao R; Fowler RA
BMC Infect Dis; 2019 May; 19(1):376. PubMed ID: 31046707
[TBL] [Abstract][Full Text] [Related]
11. [Ebola Virus Disease (Ebola Hemorrhagic Fever)].
Yanagihara K; Sasaki D; Akamatsu N; Kaku N; Kosai K
Rinsho Byori; 2016 Sep; 64(9):1025-1032. PubMed ID: 30609455
[TBL] [Abstract][Full Text] [Related]
12. Caring for patients with Ebola virus disease: Are U.S. biocontainment centers ready for the next outbreak?
Dean CL; Hill CE
Semin Diagn Pathol; 2019 May; 36(3):160-163. PubMed ID: 31010606
[TBL] [Abstract][Full Text] [Related]
13. Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014-2015 Ebola virus disease outbreak in West Africa.
Ansumana R; Keitell S; Roberts GM; Ntoumi F; Petersen E; Ippolito G; Zumla A
Int J Infect Dis; 2017 Mar; 56():101-104. PubMed ID: 27818362
[TBL] [Abstract][Full Text] [Related]
14. Utilization of non-Ebola health care services during Ebola outbreaks: a systematic review and meta-analysis.
Wilhelm JA; Helleringer S
J Glob Health; 2019 Jun; 9(1):010406. PubMed ID: 30701070
[TBL] [Abstract][Full Text] [Related]
15. Improving attrition rates in Ebola virus drug discovery.
Glisic S; Paessler S; Veljkovic N; Perovic VR; Prljic J; Veljkovic V
Expert Opin Drug Discov; 2015; 10(9):1025-32. PubMed ID: 26125997
[TBL] [Abstract][Full Text] [Related]
16. [Vaccines to prevent Ebola virus disease: current challenges and perspectives].
Kovyrshina AV; Sizikova TE; Lebedev VN; Borisevich SV; Dolzhikova IV; Logunov DY; Gintsburg AL
Vopr Virusol; 2023 Nov; 68(5):372-384. PubMed ID: 38156572
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile and containment of the Ebola virus disease outbreak in two large West African cities, Nigeria, July-September 2014.
Ohuabunwo C; Ameh C; Oduyebo O; Ahumibe A; Mutiu B; Olayinka A; Gbadamosi W; Garcia E; Nanclares C; Famiyesin W; Mohammed A; Nguku P; Koko RI; Obasanya J; Adebayo D; Gbadegesin Y; Idigbe O; Oguntimehin O; Nyanti S; Nzuki C; Abdus-Salam I; Adeyemi J; Onyekwere N; Musa E; Brett-Major D; Shuaib F; Nasidi A
Int J Infect Dis; 2016 Dec; 53():23-29. PubMed ID: 27575939
[TBL] [Abstract][Full Text] [Related]
18. Review of Ebola virus disease in children - how far have we come?
Dixit D; Masumbuko Claude K; Kjaldgaard L; Hawkes MT
Paediatr Int Child Health; 2021 Feb; 41(1):12-27. PubMed ID: 32894024
[TBL] [Abstract][Full Text] [Related]
19. Risk posed by the Ebola epidemic to the Pacific islands: findings of a recent World Health Organization assessment.
Craig AT; Ronsse A; Hardie K; Pavlin BI; Biaukula V; Nilles EJ
Western Pac Surveill Response J; 2015; 6(2):45-50. PubMed ID: 26306216
[TBL] [Abstract][Full Text] [Related]
20. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
; ; Davey RT; Dodd L; Proschan MA; Neaton J; Neuhaus Nordwall J; Koopmeiners JS; Beigel J; Tierney J; Lane HC; Fauci AS; Massaquoi MBF; Sahr F; Malvy D
N Engl J Med; 2016 Oct; 375(15):1448-1456. PubMed ID: 27732819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
